Shopping Cart
- Remove All
Your shopping cart is currently empty
SIRT2-IN-9 is a selective SRIT2 inhibitor with an IC50 value of 1.3 μM.SIRT2-IN-9 inhibits the proliferation of MCF-7 breast cancer cells.SIRT2-IN-9 can be used for cancer research.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $68 | In Stock | |
| 10 mg | $118 | In Stock | |
| 25 mg | $247 | In Stock | |
| 50 mg | $392 | In Stock | |
| 100 mg | $588 | In Stock |
| Description | SIRT2-IN-9 is a selective SRIT2 inhibitor with an IC50 value of 1.3 μM.SIRT2-IN-9 inhibits the proliferation of MCF-7 breast cancer cells.SIRT2-IN-9 can be used for cancer research. |
| Targets&IC50 | SIRT1:>300 μM, SIRT2:1.3 μM, SIRT3:>300 μM |
| In vitro | SIRT2-IN-9 (1-100 μM; 15 min) dose-dependently inhibits SIRT2 (IC50=1.3 μM) while also inhibiting SIRT1 and SIRT3 (IC50s >300 μM).[1] Additionally, SIRT2-IN-9 (0-50 μM; 72 h) affects the cell viability and dose-dependently inhibits the proliferation of MCF-7 breast cancer cells.[1] SIRT2-IN-9 (0-50 μM; 6 h) also impacts the acetylation of α-tubulin protein.[1] |
| Molecular Weight | 438.57 |
| Formula | C21H22N6OS2 |
| Cas No. | 522650-91-5 |
| Smiles | CCCn1c2ccccc2c2nnc(SCC(=O)Nc3nc4CCCCc4s3)nc12 |
| Color | Yellow |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||
| Solubility Information | DMSO: 4.0 mg/mL (9.2 mM), Sonication and heating to 70℃ are recommended. | |||||||||||||||
Solution Preparation Table | ||||||||||||||||
DMSO
| ||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.